My PhD supervisor, Bob, kindly shared his CV with me and recommended that I peruse other scientists’ research webpages for theirs. Sure enough, many researchers in my field had a link next to their ...

SEATTLE, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Shape Therapeutics, a leader in RNA-based gene therapy, today announced the acceptance of two oral presentations at the upcoming European Society of Gene ...

ST. THOMAS — University of the Virgin Islands students will deliver oral and poster presentations on their research work this weekend.

CCR5 inhibition combined with ICI therapy increased overall survival in patients with mTNBC, with 18% of heavily pretreated mTNBC patients alive after a median of ~60 months. Inhibition of CCR5 by ...

Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production solutions for the biopharmaceutical and diagnostics ...

Cosmax has achieved firsts and the highest number of accomplishments at a global cosmetics academic conference. Following Korea’s first-ever grand prize at the World Congress of Cosmetic Science, the ...

Company will provide an overview of the pritelivir clinical development program in two oral presentations including a comprehensive Phase 2 data ...

MORRISVILLE, N.C., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, ...

WILMETTE, Ill., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative ...

Following the presentation, a copy will be available on the "Program Presentations & Publications" section of the Company's website at https://www.enliventherapeutics.com. Enliven is a clinical-stage ...